Elevated prolidase activity in keloids: Correlation with type I collagen turnover

British Journal of Dermatology

Volumn 154, Issue 5, 2006, Pages 820-828

  Duong, H S ^a   Zhang, Q Z ^b   Le, A D ^b,c   Kelly, A P ^d   Kamdar, R ^a   Messadi, D V ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Aminoterminal propeptide of type I procollagen; Carboxyterminal telopeptide of type I collagen; Collagen turnover; Keloid; Prolidase

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE; COLLAGEN TYPE 1; COLLAGEN TYPE 3; GELATINASE A; INTERSTITIAL COLLAGENASE; PROLINE; PROLINE DIPEPTIDASE;

ADULT; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KELOID; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN METABOLISM; STEADY STATE; WESTERN BLOTTING;

ADOLESCENT; ADULT; CELLS; CELLS, CULTURED; COLLAGEN; COLLAGEN TYPE I; CULTURE MEDIA, CONDITIONED; DIPEPTIDASES; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION; HUMANS; IN SITU HYBRIDIZATION; KELOID; MIDDLE AGED; PROLINE; RNA, MESSENGER; SKIN;

EID: 33645805481     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2006.07167.x     Document Type: Article

References (50)

1. Rockwell WB Cohen IK Ehrlick HP. Keloids and hypertrophic scars, a comprehensive review. Plast Reconstr Surg 1989 84 827 37.
2. Kischer CW Brody GS. Structure of the collagen nodule from hypertrophic scars and keloids. Scan Electron Microsc 1981 3 371 6.
3. Uitto J Perejda AJ Abergel RP et al. Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci USA 1985 82 5935 9.
4. Abergel RP Pizzuro D Meeker CA et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985 84 384 90.
5. Russel JD Witt WS. Cell size and growth characteristics of cultured fibroblasts isolated from normal and keloid tissue. Plast Reconstr Surg 1976 57 207 12.
6. Ala-Kokko L Rintala A Savolainen ER. Collagen gene expression in keloids: analysis of collagen metabolism and type I, III, IV, and V procollagen mRNAs in keloid tissue and keloid fibroblast cultures. J Invest Dermatol 1987 89 238 44.
7. Uitto J Kouba D. Cytokine modulation of extracellular gene expression: relevance to fibrotic skin disease. J Dermatol Sci 2000 24 Suppl. 1 S60 9.
8. Chevray PM Manson PN. Keloid scars are formed by polyclonal fibroblasts. Ann Plastic Surg 2004 52 605 8.
9. Cohen IK Diegelman RF Keisser HR. Collagen metabolism in keloid and hypertrophic scars. Surg Forum 1971 22 488 9.
10. Harris ED Jr. Sjoerdsma A. Collagen profile in various clinical conditions. Lancet 1966 ii 707 11.
11. Craig P. Collagenase activity in cutaneous scars. Hand 1983 5 239 41.
12. McCoy BJ Cohen IK. Collagenase in keloid biopsies and fibroblasts. Connect Tissue Res 1982 9 181 5.
13. Phan TT See P Tran E et al. Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in treatment and/or prevention of keloids. Br J Dermatol 2003 148 544 52.
14. Oriente A Fedarko NS Pacoha SE et al. Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 2000 292 988 94.
15. Ladin DA Garner WL Smith DJ. Excessive scarring as a consequence of healing. Wound Repair Regen 1995 3 6 14.
16. Craig SS DeBlois G Schwartz LB. Mast cells in human keloid, small intestine and lung by an immunoperoxidase technique using a murine monoclonal antibody against tryptase. Am J Pathol 1986 124 427 35.
17. Prockop DJ Kivirikko KI Tuderman L et al. The biosynthesis of collagen and its disorders. N Engl J Med 1979 301 77 85.
18. Oikarinen A Autio P Kiistala U et al. A new method to measure type I and III collagen synthesis in human skin in vivo: demonstration of decreased collagen synthesis after topical glucocorticoid treatment. J Invest Dermatol 1992 98 220 5.
19. Ono S Imai T Shimizu N et al. Serum markers of type I collagen synthesis and degradation in amyotrophic lateral sclerosis. Eur Neurol 2000 44 49 56.
20. Melkko J Niemi S Risteli L et al. Immunoassay for intact amino-terminal propeptide of human type I procollagen. Clin Chem 1996 42 947 54.
21. Palka JA Phang JM. Prolidase activity in fibroblast is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 1997 67 166 75.
22. Ono T Fujiwara Y Yoshioka T et al. Prolidase activity in chronic wound and blister fluids. J Dermatol 1997 24 626 9.
23. Senboshi Y Oono T Arata J. Localization of prolidase gene expression in scar tissue using in situ hybridization. J Dermatol Sci 1996 12 163 71.
24. Abraham P Wilfred G Ramakrishna B. Plasma prolidase may be an index of liver fibrosis in the rat. Clin Chim Acta 1997 295 199 202.
25. Chamson A Voigtlander V Myara I et al. Collagen biosynthetic anomalies in prolidase deficiency: effect of glycyl- l -proline on the degradation of newly synthesized collagen. Clin Physiol Biochem 1989 7 128 36.
26. Jackson SH Dennis AW Greenberg M. Iminopeptiduria, a genetic defect in recycling of collagen: a method for determining prolidase in red blood cells. Cancer Res 1975 113 759 63.
27. Messadi DV Le A Berg S et al. Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen 1999 7 511 17.
28. Karna E Surazynski A Palka JA. Collagen metabolism disturbances are accompanied by an increase in prolidase activity in lung carcinoma planoepitheliale. J Exp Pathol 2000 81 341 7.
29. Myara I Myara A Mangeot M et al. Plasma prolidase activity: a possible index of collagen catabolism in chronic liver disease. Clin Chem 1984 30 211 15.
30. Chinard FP. Photometric estimation of proline and ornithine. J Biol Chem 1952 199 91 5.
31. Melkko J Niemi S Risteli L et al. Radioimmunoassay of the carboxy-terminal telopeptide of human type I procollagen. Clin Chem 1991 36 1328 32.
32. Risteli J Elomaa I Niemi S et al. Radioimmunoassay for the pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993 39 563 9.
33. Messadi DV Duong HS Zhang QZ et al. Activation of NFκB signal pathways in keloid fibroblasts. Arch Dermatol Res 2004 296 125 33.
34. Kikuchi K Sato S Kadono T et al. Serum concentration of procollagen type I carboxyterminal propeptide in localized scleroderma. Arch Dermatol 1994 130 1269 72.
35. Diegelmann RF Cohen IK McCoy BJ. Growth kinetics and collagen synthesis of normal skin, normal scar and keloid fibroblasts in vitro. J Cell Physiol 1979 98 341 6.
36. Tuan TL Wu H Huang EY et al. Increased plasminogen activator inhibitor-1 in keloid fibroblasts may account for their elevated collagen accumulation in fibrin gel cultures. Am J Pathol 2003 162 1579 89.
37. Phan TT Lim IJ Bay BH et al. Differences in collagen production between normal and keloid-derived fibroblasts in serum co-culture with keloid-derived keratinocytes. J Dermatol Sci 2002 29 26 34.
38. Sasaki T Majama K Uitto J. Reduction of collagen production in keloid fibroblast cultures by ethyl-3,4-dihydroxybenzoate. J Biol Chem 1987 262 9397 403.
39. Uzawa K Marshall MK Katz EP et al. Altered posttranslational modification of collagen in keloid. Biochem Biophys Res Commun 1998 249 652 5.
40. Sato M Ishikawa O Miyachi Y. Distinct patterns of collagen gene expression are seen in normal and keloid fibroblasts grown in three-dimensional culture. Br J Dermatol 1998 138 938 43.
41. Miltyk W Karna E Palka JA. Inhibition of prolidase activity by non-steroid antiinflamatory drugs in cultured human skin fibroblasts. Pol J Pharmacol 1996 48 609 13.
42. Calvo SM Eype DR Gundberg CM. Molecular basis and clinical application of biological markers of bone turnover. Endocrine Rev 1996 17 333 68.
43. Kubo T Tanaka H Inoue S et al. Serum levels of carboxyterminal propeptide of type I procollagen and pyridinoline crosslinked telopeptide of type I collagen in normal children with growth hormone deficiency during GH therapy. Bone 1995 17 397 401.
44. Knuutinen A Kokkonen N Ristelli J et al. Smoking affects collagen synthesis and extracellular matrix turnover in human skin. Br J Dermatol 2002 146 588 94.
45. Cukierman E Pankov R Stevens DR Yamada KM. Taking cell-matrix adhesions to the third dimension. Science 2001 294 1708 12.
46. Cukierman E Pankov R Yamada KM. Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 2002 14 633 9.
47. Danen E Lafranie RM Miyamato S Yamada KM. Integrin signaling: cytoskeletal complexes, MAP kinase activation, and regulation of gene expression. Cell Adhesion Commun 1998 6 217 24.
48. Lim IJ Phan TT Tan EK et al. Synchronous activation of ERK and phosphatidylinositol 3-kinase pathways is required for collagen and ECM productions in keloids. J Biol Chem 2003 278 40851 8.
49. 1-integrin signaling in cultured fibroblasts. Med Sci Monit 2004 10 BR175 9.
50. Croce MA Silvestri C Guerra D et al. Adhesion and proliferation of human dermal fibroblasts on collagen matrix. J Biomater Appl 2004 18 209 22.